Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long non-coding RNA for programmed cell death 5 and p53 stability (LNPPS) is a long non-coding RNA transcript (ENST00000622374) discovered in the context of bladder cancer. LNPPS acts as a scaffold, physically connecting PDCD5 and the tumor suppressor protein p53 via distinct nucleotide regions, thereby enhancing their interaction. This lncRNA protects PDCD5 from proteasomal degradation by masking its ubiquitination at K20, and disrupts MDM2-mediated ubiquitination of p53, increasing p53 stability and promoting apoptosis. LNPPS is typically downregulated in bladder cancer tissues due to reduced N6-methyladenosine (m6A) modification, contributing to tumor survival. Restoration or enhancement of LNPPS expression in cancer cells leads to upregulation of p53 and activation of apoptosis pathways, marking it as a potent tumor suppressor and a potential therapeutic target for bladder cancer and possibly other malignancies where the PDCD5/p53 axis plays a role[1][3].
Scaffold-mediated inhibition of ubiquitination (prevents PDCD5 ubiquitination at K20, impairs MDM2-mediated ubiquitination of p53), Stabilization of p53 and PDCD5, Activation of p53-dependent apoptosis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long non-coding RNA for programmed cell death 5 and p53 stability (LNPPS).